Since 2017, Iason Gabriel has worked at the tech giant, trying to anticipate – and think through – the impact of AI. But as commercial and geopolitical pressures escalate, can ethicists make any ...
Drug discovery has long been a slow, expensive process of trial and error, and for a small clinical-stage company, every wasted experiment is capital it can scarcely afford. That is the backdrop for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results